Global Cell Therapy and Gene Therapy CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Cell Therapy and Gene Therapy CDMO market size was valued at USD 3210.3 million in 2022 and is forecast to a readjusted size of USD 10940 million by 2029 with a CAGR of 19.1% during review period.

Cell and Gene Therapy (CGT for short, excluding broad cell therapies such as unmodified stem cells) is a method of using gene therapy vectors to transduce exogenous therapeutic genes into cells, and then through external Transcription and translation of source genes, a method of changing the original gene expression of cells to treat diseases.

The Global Info Research report includes an overview of the development of the Cell Therapy and Gene Therapy CDMO industry chain, the market status of Clinical Stage Projects (Cell Therapy, Gene Therapy), Commercialization Stage Projects (Cell Therapy, Gene Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell Therapy and Gene Therapy CDMO.

Regionally, the report analyzes the Cell Therapy and Gene Therapy CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell Therapy and Gene Therapy CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell Therapy and Gene Therapy CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell Therapy and Gene Therapy CDMO industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cell Therapy, Gene Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell Therapy and Gene Therapy CDMO market.

Regional Analysis: The report involves examining the Cell Therapy and Gene Therapy CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell Therapy and Gene Therapy CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell Therapy and Gene Therapy CDMO:
Company Analysis: Report covers individual Cell Therapy and Gene Therapy CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell Therapy and Gene Therapy CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Stage Projects, Commercialization Stage Projects).

Technology Analysis: Report covers specific technologies relevant to Cell Therapy and Gene Therapy CDMO. It assesses the current state, advancements, and potential future developments in Cell Therapy and Gene Therapy CDMO areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell Therapy and Gene Therapy CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell Therapy and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Cell Therapy
    Gene Therapy

Market segment by Application
    Clinical Stage Projects
    Commercialization Stage Projects

Market segment by players, this report covers
    Lonza Pharmaceuticals
    Thermo Fisher
    catalent
    Jubilant LifeSciences
    Boehringer Ingelheim
    Oxford BioMedica
    Charles River
    WuXi AppTec
    He Yuan Biology
    GenScript Biotech
    Kanglong Chemical
    Porton shares
    Sano Biologics
    Yunzhou Biology

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Therapy and Gene Therapy CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy and Gene Therapy CDMO, with revenue, gross margin and global market share of Cell Therapy and Gene Therapy CDMO from 2018 to 2023.
Chapter 3, the Cell Therapy and Gene Therapy CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Therapy and Gene Therapy CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy and Gene Therapy CDMO.
Chapter 13, to describe Cell Therapy and Gene Therapy CDMO research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell Therapy and Gene Therapy CDMO
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell Therapy and Gene Therapy CDMO by Type
        1.3.1 Overview: Global Cell Therapy and Gene Therapy CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
        1.3.3 Cell Therapy
        1.3.4 Gene Therapy
    1.4 Global Cell Therapy and Gene Therapy CDMO Market by Application
        1.4.1 Overview: Global Cell Therapy and Gene Therapy CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Clinical Stage Projects
        1.4.3 Commercialization Stage Projects
    1.5 Global Cell Therapy and Gene Therapy CDMO Market Size & Forecast
    1.6 Global Cell Therapy and Gene Therapy CDMO Market Size and Forecast by Region
        1.6.1 Global Cell Therapy and Gene Therapy CDMO Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell Therapy and Gene Therapy CDMO Market Size by Region, (2018-2029)
        1.6.3 North America Cell Therapy and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell Therapy and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.6 South America Cell Therapy and Gene Therapy CDMO Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell Therapy and Gene Therapy CDMO Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Lonza Pharmaceuticals
        2.1.1 Lonza Pharmaceuticals Details
        2.1.2 Lonza Pharmaceuticals Major Business
        2.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.1.4 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lonza Pharmaceuticals Recent Developments and Future Plans
    2.2 Thermo Fisher
        2.2.1 Thermo Fisher Details
        2.2.2 Thermo Fisher Major Business
        2.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.2.4 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Thermo Fisher Recent Developments and Future Plans
    2.3 catalent
        2.3.1 catalent Details
        2.3.2 catalent Major Business
        2.3.3 catalent Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.3.4 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 catalent Recent Developments and Future Plans
    2.4 Jubilant LifeSciences
        2.4.1 Jubilant LifeSciences Details
        2.4.2 Jubilant LifeSciences Major Business
        2.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.4.4 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Jubilant LifeSciences Recent Developments and Future Plans
    2.5 Boehringer Ingelheim
        2.5.1 Boehringer Ingelheim Details
        2.5.2 Boehringer Ingelheim Major Business
        2.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.5.4 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.6 Oxford BioMedica
        2.6.1 Oxford BioMedica Details
        2.6.2 Oxford BioMedica Major Business
        2.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.6.4 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Oxford BioMedica Recent Developments and Future Plans
    2.7 Charles River
        2.7.1 Charles River Details
        2.7.2 Charles River Major Business
        2.7.3 Charles River Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.7.4 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Charles River Recent Developments and Future Plans
    2.8 WuXi AppTec
        2.8.1 WuXi AppTec Details
        2.8.2 WuXi AppTec Major Business
        2.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.8.4 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 WuXi AppTec Recent Developments and Future Plans
    2.9 He Yuan Biology
        2.9.1 He Yuan Biology Details
        2.9.2 He Yuan Biology Major Business
        2.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.9.4 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 He Yuan Biology Recent Developments and Future Plans
    2.10 GenScript Biotech
        2.10.1 GenScript Biotech Details
        2.10.2 GenScript Biotech Major Business
        2.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.10.4 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 GenScript Biotech Recent Developments and Future Plans
    2.11 Kanglong Chemical
        2.11.1 Kanglong Chemical Details
        2.11.2 Kanglong Chemical Major Business
        2.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.11.4 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Kanglong Chemical Recent Developments and Future Plans
    2.12 Porton shares
        2.12.1 Porton shares Details
        2.12.2 Porton shares Major Business
        2.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.12.4 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Porton shares Recent Developments and Future Plans
    2.13 Sano Biologics
        2.13.1 Sano Biologics Details
        2.13.2 Sano Biologics Major Business
        2.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.13.4 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sano Biologics Recent Developments and Future Plans
    2.14 Yunzhou Biology
        2.14.1 Yunzhou Biology Details
        2.14.2 Yunzhou Biology Major Business
        2.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Solutions
        2.14.4 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Yunzhou Biology Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell Therapy and Gene Therapy CDMO Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell Therapy and Gene Therapy CDMO by Company Revenue
        3.2.2 Top 3 Cell Therapy and Gene Therapy CDMO Players Market Share in 2022
        3.2.3 Top 6 Cell Therapy and Gene Therapy CDMO Players Market Share in 2022
    3.3 Cell Therapy and Gene Therapy CDMO Market: Overall Company Footprint Analysis
        3.3.1 Cell Therapy and Gene Therapy CDMO Market: Region Footprint
        3.3.2 Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
        3.3.3 Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell Therapy and Gene Therapy CDMO Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell Therapy and Gene Therapy CDMO Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    6.2 North America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    6.3 North America Cell Therapy and Gene Therapy CDMO Market Size by Country
        6.3.1 North America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        6.3.2 United States Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    7.2 Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country
        7.3.1 Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.3 France Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell Therapy and Gene Therapy CDMO Market Size by Region
        8.3.1 Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2029)
        8.3.2 China Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.5 India Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    9.2 South America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    9.3 South America Cell Therapy and Gene Therapy CDMO Market Size by Country
        9.3.1 South America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Country
        10.3.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell Therapy and Gene Therapy CDMO Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell Therapy and Gene Therapy CDMO Market Drivers
    11.2 Cell Therapy and Gene Therapy CDMO Market Restraints
    11.3 Cell Therapy and Gene Therapy CDMO Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Cell Therapy and Gene Therapy CDMO Industry Chain
    12.2 Cell Therapy and Gene Therapy CDMO Upstream Analysis
    12.3 Cell Therapy and Gene Therapy CDMO Midstream Analysis
    12.4 Cell Therapy and Gene Therapy CDMO Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Lonza Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 6. Lonza Pharmaceuticals Major Business
    Table 7. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 8. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Lonza Pharmaceuticals Recent Developments and Future Plans
    Table 10. Thermo Fisher Company Information, Head Office, and Major Competitors
    Table 11. Thermo Fisher Major Business
    Table 12. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 13. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Thermo Fisher Recent Developments and Future Plans
    Table 15. catalent Company Information, Head Office, and Major Competitors
    Table 16. catalent Major Business
    Table 17. catalent Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 18. catalent Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. catalent Recent Developments and Future Plans
    Table 20. Jubilant LifeSciences Company Information, Head Office, and Major Competitors
    Table 21. Jubilant LifeSciences Major Business
    Table 22. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 23. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Jubilant LifeSciences Recent Developments and Future Plans
    Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 26. Boehringer Ingelheim Major Business
    Table 27. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 28. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Boehringer Ingelheim Recent Developments and Future Plans
    Table 30. Oxford BioMedica Company Information, Head Office, and Major Competitors
    Table 31. Oxford BioMedica Major Business
    Table 32. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 33. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Oxford BioMedica Recent Developments and Future Plans
    Table 35. Charles River Company Information, Head Office, and Major Competitors
    Table 36. Charles River Major Business
    Table 37. Charles River Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 38. Charles River Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Charles River Recent Developments and Future Plans
    Table 40. WuXi AppTec Company Information, Head Office, and Major Competitors
    Table 41. WuXi AppTec Major Business
    Table 42. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 43. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. WuXi AppTec Recent Developments and Future Plans
    Table 45. He Yuan Biology Company Information, Head Office, and Major Competitors
    Table 46. He Yuan Biology Major Business
    Table 47. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 48. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. He Yuan Biology Recent Developments and Future Plans
    Table 50. GenScript Biotech Company Information, Head Office, and Major Competitors
    Table 51. GenScript Biotech Major Business
    Table 52. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 53. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. GenScript Biotech Recent Developments and Future Plans
    Table 55. Kanglong Chemical Company Information, Head Office, and Major Competitors
    Table 56. Kanglong Chemical Major Business
    Table 57. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 58. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Kanglong Chemical Recent Developments and Future Plans
    Table 60. Porton shares Company Information, Head Office, and Major Competitors
    Table 61. Porton shares Major Business
    Table 62. Porton shares Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 63. Porton shares Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Porton shares Recent Developments and Future Plans
    Table 65. Sano Biologics Company Information, Head Office, and Major Competitors
    Table 66. Sano Biologics Major Business
    Table 67. Sano Biologics Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 68. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Sano Biologics Recent Developments and Future Plans
    Table 70. Yunzhou Biology Company Information, Head Office, and Major Competitors
    Table 71. Yunzhou Biology Major Business
    Table 72. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product and Solutions
    Table 73. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Yunzhou Biology Recent Developments and Future Plans
    Table 75. Global Cell Therapy and Gene Therapy CDMO Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Cell Therapy and Gene Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Cell Therapy and Gene Therapy CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Cell Therapy and Gene Therapy CDMO Players
    Table 80. Cell Therapy and Gene Therapy CDMO Market: Company Product Type Footprint
    Table 81. Cell Therapy and Gene Therapy CDMO Market: Company Product Application Footprint
    Table 82. Cell Therapy and Gene Therapy CDMO New Market Entrants and Barriers to Market Entry
    Table 83. Cell Therapy and Gene Therapy CDMO Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Cell Therapy and Gene Therapy CDMO Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Cell Therapy and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
    Table 86. Global Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023)
    Table 88. Global Cell Therapy and Gene Therapy CDMO Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Cell Therapy and Gene Therapy CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Cell Therapy and Gene Therapy CDMO Raw Material
    Table 120. Key Suppliers of Cell Therapy and Gene Therapy CDMO Raw Materials
List of Figures
    Figure 1. Cell Therapy and Gene Therapy CDMO Picture
    Figure 2. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type in 2022
    Figure 4. Cell Therapy
    Figure 5. Gene Therapy
    Figure 6. Global Cell Therapy and Gene Therapy CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application in 2022
    Figure 8. Clinical Stage Projects Picture
    Figure 9. Commercialization Stage Projects Picture
    Figure 10. Global Cell Therapy and Gene Therapy CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Cell Therapy and Gene Therapy CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Market Cell Therapy and Gene Therapy CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 13. Global Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 14. Global Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Region in 2022
    Figure 15. North America Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 16. Europe Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 17. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 18. South America Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Middle East and Africa Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Global Cell Therapy and Gene Therapy CDMO Revenue Share by Players in 2022
    Figure 21. Cell Therapy and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 22. Global Top 3 Players Cell Therapy and Gene Therapy CDMO Market Share in 2022
    Figure 23. Global Top 6 Players Cell Therapy and Gene Therapy CDMO Market Share in 2022
    Figure 24. Global Cell Therapy and Gene Therapy CDMO Consumption Value Share by Type (2018-2023)
    Figure 25. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Type (2024-2029)
    Figure 26. Global Cell Therapy and Gene Therapy CDMO Consumption Value Share by Application (2018-2023)
    Figure 27. Global Cell Therapy and Gene Therapy CDMO Market Share Forecast by Application (2024-2029)
    Figure 28. North America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 29. North America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 30. North America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 31. United States Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 32. Canada Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 33. Mexico Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 34. Europe Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 35. Europe Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 36. Europe Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 37. Germany Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 38. France Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 39. United Kingdom Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 40. Russia Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 41. Italy Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 42. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 43. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 44. Asia-Pacific Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 45. China Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 46. Japan Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 47. South Korea Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 48. India Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 49. Southeast Asia Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 50. Australia Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 51. South America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 52. South America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 53. South America Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 54. Brazil Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 55. Argentina Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 56. Middle East and Africa Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 57. Middle East and Africa Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 58. Middle East and Africa Cell Therapy and Gene Therapy CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 59. Turkey Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 60. Saudi Arabia Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 61. UAE Cell Therapy and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 62. Cell Therapy and Gene Therapy CDMO Market Drivers
    Figure 63. Cell Therapy and Gene Therapy CDMO Market Restraints
    Figure 64. Cell Therapy and Gene Therapy CDMO Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Cell Therapy and Gene Therapy CDMO in 2022
    Figure 67. Manufacturing Process Analysis of Cell Therapy and Gene Therapy CDMO
    Figure 68. Cell Therapy and Gene Therapy CDMO Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Companies Mentioned

Lonza Pharmaceuticals
Thermo Fisher
catalent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Sano Biologics
Yunzhou Biology